Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients

[Figure: see text]

Detalles Bibliográficos
Autores principales: Calò, Lorenzo A., Bertoldi, Giovanni, Davis, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217778/
https://www.ncbi.nlm.nih.gov/pubmed/32430287
http://dx.doi.org/10.1016/j.phrs.2020.104903
_version_ 1783532656635412480
author Calò, Lorenzo A.
Bertoldi, Giovanni
Davis, Paul A.
author_facet Calò, Lorenzo A.
Bertoldi, Giovanni
Davis, Paul A.
author_sort Calò, Lorenzo A.
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-7217778
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72177782020-05-13 Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients Calò, Lorenzo A. Bertoldi, Giovanni Davis, Paul A. Pharmacol Res Article [Figure: see text] Elsevier Ltd. 2020-08 2020-05-13 /pmc/articles/PMC7217778/ /pubmed/32430287 http://dx.doi.org/10.1016/j.phrs.2020.104903 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Calò, Lorenzo A.
Bertoldi, Giovanni
Davis, Paul A.
Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
title Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
title_full Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
title_fullStr Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
title_full_unstemmed Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
title_short Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients
title_sort rho kinase inhibitors for sars-cov-2 induced acute respiratory distress syndrome: support from bartter’s and gitelman’s syndrome patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217778/
https://www.ncbi.nlm.nih.gov/pubmed/32430287
http://dx.doi.org/10.1016/j.phrs.2020.104903
work_keys_str_mv AT calolorenzoa rhokinaseinhibitorsforsarscov2inducedacuterespiratorydistresssyndromesupportfrombarttersandgitelmanssyndromepatients
AT bertoldigiovanni rhokinaseinhibitorsforsarscov2inducedacuterespiratorydistresssyndromesupportfrombarttersandgitelmanssyndromepatients
AT davispaula rhokinaseinhibitorsforsarscov2inducedacuterespiratorydistresssyndromesupportfrombarttersandgitelmanssyndromepatients

Ejemplares similares